THURSDAY, July 6, 2023 (HealthDay News) — Decades of “redlining” — discriminatory policies that led to disinvestment in minority communities within the United States — may be connected with current cases of kidney failure in Black adults. A new study from researchers at Boston University School of Public Health (BUSPH)Continue Reading

THURSDAY, July 6, 2023 (HealthDay News) — New research finds that Medicaid expansion under the Affordable Care Act — also known as Obamacare — brought an unexpected benefit: increases in how many patients got palliative care. “Our findings are encouraging, especially with growing evidence of the important benefits of palliativeContinue Reading

WEDNESDAY, July 5, 2023 (HealthDay News) — Several companies are selling copycat food items that have the potential to trick people, including children, into consuming dangerous quantities of cannabis. On Wednesday the U.S. Food and Drug Administration and the Federal Trade Commission warned six companies about selling these copycat foodContinue Reading

WEDNESDAY, July 5, 2023 (HealthDay News) — Youth who are both LGBTQ+ and either Black or Hispanic and live in U.S. states that have discriminatory policies are more likely to have depression than their counterparts in states that are more affirming to gender and sexual identity, new research finds. “ThisContinue Reading

THURSDAY, June 29, 2023 (HealthDay News) — Children with disabilities are discriminated against in health care settings — to the detriment of their health, according to their parents. Thirty in-depth interviews with parents of children with disabilities revealed a disturbingly common thread. “They mistreated her and treated her like aContinue Reading

WEDNESDAY, June 28, 2023 (HealthDay News) — A new study shows that older Americans with health issues are now staying with their Medicare Advantage managed plans, rather than swapping them for traditional plans through a health insurer. Although Medicare Advantage has been criticized in the past for “cherry-picking” healthy patients,Continue Reading

FRIDAY, June 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the drug Elevidys, the first gene therapy for the treatment of children with Duchenne muscular dystrophy (DMD). The groundbreaking treatment will not be cheap: Drugmaker Sarepta Therapeutics Inc. said it would charge $3.2 millionContinue Reading